Cargando…

Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides

BACKGROUND: Cytotoxic Natural Killer (NK) cells are increasingly recognized as a powerful tool to induce targeted cell death in cancer and autoimmune diseases. Still, basic blood NK cell parameters are poorly defined. The aims of this study were 1) to establish reference values of NK cell counts and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merkt, Wolfgang, Salzer, Ulrich, Thiel, Jens, Jandova, Ilona, Bergner, Raoul, Venhoff, Ana C., Venhoff, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040212/ https://www.ncbi.nlm.nih.gov/pubmed/33840389 http://dx.doi.org/10.1186/s12865-021-00416-w

Ejemplares similares

Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides
por: Giaglis, Stavros, et al.
Publicado: (2023)

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
por: Venhoff, Nils, et al.
Publicado: (2012)

B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
por: Thiel, Jens, et al.
Publicado: (2017)

ANCA-associated vasculitides in childhood
por: Garan, Diána, et al.
Publicado: (2011)

Overlap between dermatomyositis and ANCA vasculitides
por: Yuste, Claudia, et al.
Publicado: (2014)

Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients
por: Venhoff, Nils, et al.
Publicado: (2021)

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2020)

Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms
por: Frede, Natalie, et al.
Publicado: (2023)

Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2021)

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
por: Zeisbrich, Markus, et al.
Publicado: (2021)

Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis
por: Zeisbrich, Markus, et al.
Publicado: (2022)

T-helper cells as new players in ANCA-associated vasculitides
por: Abdulahad, Wayel H, et al.
Publicado: (2011)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
por: Thiel, Jens, et al.
Publicado: (2013)

B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide
por: Thiel, Jens, et al.
Publicado: (2011)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections
por: Poirot-Seynaeve, Xavier, et al.
Publicado: (2023)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides
por: Bonaci-Nikolic, Branka, et al.
Publicado: (2005)

The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement
por: Venhoff, Nils, et al.
Publicado: (2019)

Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity
por: Briones, Melissa R, et al.
Publicado: (2017)

Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis
por: Ramirez, Giuseppe A., et al.
Publicado: (2015)

T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides
por: Greulich, Simon, et al.
Publicado: (2017)

A rare case of spontaneous renal rupture caused by ANCA - associated vasculitides
por: Yu, Yongquan, et al.
Publicado: (2018)

ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
por: Folci, Marco, et al.
Publicado: (2019)

Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
por: Toyoda, Task, et al.
Publicado: (2022)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Azathioprine-induced Sweet syndrome in ANCA-associated vasculitis
por: Neild, G. H., et al.
Publicado: (2013)

Beyond Uterine Natural Killer Cell Numbers in Unexplained Recurrent Pregnancy Loss: Combined Analysis of CD45, CD56, CD16, CD57, and CD138
por: Chiokadze, Maia, et al.
Publicado: (2020)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells
por: Merkt, Wolfgang, et al.
Publicado: (2016)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Key Role of the CD56(low)CD16(low) Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
por: Vulpis, Elisabetta, et al.
Publicado: (2018)

The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment
por: Cui, Feng, et al.
Publicado: (2019)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_60bupeq6vsru471pf012du2bum